ドラッグデリバリーデバイスの世界市場:装置タイプ別(スマートピル、吸入器・ネブライザー、薬物溶出ステント、安全シリンジ、埋め込み型薬物送達デバイス、経皮パッチ、その他)、エンドユーザー別

◆英語タイトル:Drug Delivery Devices Market by Device Type (Smart Pills, Inhalers & Nebulizers, Drug Eluting Stents, Safety Syringes, Implantable Drug Delivery Device, and Transdermal Patches, and, Others), End User (Hospitals and Diagnostic Centers, Ambulatory Surgery Centers and Clinics and Others), Global Opportunity Analysis and Industry Forecast, 2019–2026
◆商品コード:AMR20JN060
◆発行会社(リサーチ会社):Allied Market Research
◆発行日:2020年3月
◆ページ数:201
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール(受注後24時間以内)
◆調査対象地域:グローバル
◆販売価格オプション(消費税別)
Single UserUSD5,370 ⇒換算¥558,480見積依頼/購入/質問フォーム
5 UserUSD6,450 ⇒換算¥670,800見積依頼/購入/質問フォーム
Enterprise UserUSD8,995 ⇒換算¥935,480見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はAllied Market Research社の日本における正規販売代理店です。同社発行の医療分野調査レポートに関するお問い合わせは弊社までお願い致します。
Allied Market Research社の概要はこちらでご確認いただけます。
※上記「見積依頼/購入/質問フォーム」をクリックすると弊社運営のレポート販売サイトに移動します。

本調査レポートでは、ドラッグデリバリーデバイスの世界市場を調査・分析することにより、イントロダクション、エグゼクティブサマリー、市場概要、装置タイプ別(スマートピル、吸入器・ネブライザー、薬物溶出ステント、安全シリンジ、埋め込み型薬物送達デバイス、経皮パッチ、その他)分析、エンドユーザー別分析、地域別、企業情報と今後の方向性を明らかに致します。
・イントロダクション
・エグゼクティブサマリー
・市場概要
・ドラッグデリバリーデバイスの世界市場:装置タイプ別(スマートピル、吸入器・ネブライザー、薬物溶出ステント、安全シリンジ、埋め込み型薬物送達デバイス、経皮パッチ、その他)
・ドラッグデリバリーデバイスの世界市場:エンドユーザー別
・地域別
・企業情報
【レポートの概要】

The global drug delivery devices market accounted for $19,061 million in 2018, and is expected to reach $26,742 million by 2026, registering a CAGR of 4.3% from 2019 to 2026.
Drug delivery is the process of administering a pharmaceutical compound to provide therapy to various diseases. The drug delivery technologies change the profile of drug release, including absorption, distribution, and elimination to improve product safety and efficacy. It also sees the patient convenience and compliance with the drug. The common routes of administration are the oral, enteral, parenteral, inhalation, topical, and transdermal patches routes. However, many medications such as protein and peptide, antibody, vaccine, and gene-based drugs may not be delivered through these routes of administrations, as they might be vulnerable to enzymatic degradation or cannot be absorbed into the systemic circulation efficiently. This is attributed to the molecular size and its therapeutic effects. Hence, many protein and peptide drugs are recommended to be delivered by injection. Recently, manufacturers are taking many efforts in the area of drug delivery, including the development of targeted drug delivery devices in which the drug is only active in the target area of the body.
The key factors that drive the growth of the drug delivery devices market include rise in prevalence of chronic diseases and increase in the biologics market. In addition, surge in geriatric population further supplements the growth of the market. However, risk of needlestick injuries and stringent government regulations hinder the growth of the market globally. On the contrary, high growth prospects in emerging markets can provide newer opportunities for the drug delivery devices market growth.
The drug delivery devices market size is studied on the basis of device type, route of administration, and region to provide a detailed assessment of the market. On the basis of device type, it is segmented into smart pills, inhalers, drug eluting stents, safety syringes, implantable drug delivery device, transdermal patches, and others. By route of administration, it is bifurcated into hospitals & diagnostic centers, ambulatory surgical centers & clinics, and others. Region wise, it is analyzed across North America (the U.S., Canada, and Mexico), Europe (Germany, France, the UK, Italy, Spain, and rest of Europe), Asia-Pacific (China, Japan, India, Australia, South Korea, and rest of Asia-Pacific), and LAMEA (Brazil, South Africa, and rest of LAMEA).

KEY BENEFITS FOR STAKEHOLDERS
• This report entails a detailed quantitative analysis along with the current global drug delivery devicesmarket trends from 2019 to 2026 to identify the prevailing opportunities along with the strategic assessments.
• The market size and estimations are based on a comprehensive analysis of key developments in the industry.
• A qualitative analysis based on innovative products facilitates strategic business planning.
• The development strategies adopted by the key market players are enlisted to understand the competitive scenario of the market

Key Market Segments
• By Device type
o Smart pills
o Inhalers
o Drug eluting stents
o Safety syringes
o Implantable drug delivery device
o Transdermal patches
o Others

• By End User
o Hospitals & Diagnostic Centers
o Ambulatory Surgical Centers & Clinics
o Others
• By Region
o North America
 U.S.
 Canada
 Mexico
o Europe
 Germany
 France
 UK
 Italy
 Rest of Europe
o Asia-Pacific
 Japan
 China
 India
 Rest of Asia-Pacific
o LAMEA
 Brazil
 Saudi Arabia
 South Africa
 Rest of LAMEA
• List of key players profiled in the report:
• 3M Company
• AstraZeneca PLC
• Becton, Dickinson and Company
• Boehringer Ingelheim group
• Consort Medical plc
• GlaxoSmithKline plc,
• Insulet Corporation, Medtronic Plc
• Sulzer Ltd. (Medmix Systems AG)
• West Pharmaceuticals Services, Inc
LIST OF OTHER PLAYERS IN THE VALUE CHAIN(These players are not profiled in the report. The same will be included on request)
• GlaxoSmithKline plc
• Novo Nordisk A/S

【レポートの目次】

CHAPTER 1: INTRODUCTION
1.1. Report description
1.2. Key benefits for stakeholders
1.3. Key market segments
1.3.1. List of key players profiled in the report
1.4. Research methodology
1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools and models
CHAPTER 2: EXECUTIVE SUMMARY
2.1. Key findings of the study
2.2. CXO perspective
CHAPTER 3: MARKET OVERVIEW
3.1. Market definition and scope
3.2. Top player positioning
3.2.1. Top investment pockets
3.3. Porter’s five force analysis
3.4. Market dynamics
3.4.1. Drivers
3.4.1.1. Rising prevalence of chronic diseases
3.4.1.2. Growth in the biologics market
3.4.1.3. Rapid rise in the aging population
3.4.2. Restraints
3.4.2.1. Risk of needlestick injuries
3.4.2.2. Stringent government regulations
3.4.3. Opportunity
3.4.3.1. High growth prospects in the emerging markets
3.4.4. Impact Analyses
CHAPTER 4: DRUG DELIVERY DEVICES MARKET, BY DEVICE TYPE
4.1. Overview
4.1.1. Market size and forecast
4.2. Smart pills
4.2.1. Key market trends, growth factors, and opportunities
4.2.2. Market size and forecast, by region
4.2.3. Market analysis, by country
4.3. Inhalers and Nebulizers
4.3.1. Key market trends, growth factors, and opportunities
4.3.2. Market size and forecast, by region
4.3.3. Market analysis, by country
4.4. Drug Eluting Stents
4.4.1. Key market trends, growth factors, and opportunities
4.4.2. Market size and forecast, by region
4.4.3. Market analysis, by country
4.5. Safety Syringes
4.5.1. Key market trends, growth factors, and opportunities
4.5.2. Market size and forecast, by region
4.5.3. Market analysis, by country
4.6. Transdermal Patches
4.6.1. Key market trends, growth factors, and opportunities
4.6.2. Market size and forecast, by region
4.6.3. Market analysis, by country
4.7. Others
4.7.1. Key market trends, growth factors, and opportunities
4.7.2. Market size and forecast, by region
4.7.3. Market analysis, by country
CHAPTER 5: GLOBAL DRUG DELIVERY DEVICES MARKET, BY END USER
5.1. Overview
5.1.1. Market size and forecast
5.2. Hospitals and Diagnostic Centers
5.2.1. Market size and forecast, by region
5.2.2. Market analysis, by country
5.3. Ambulatory Surgery Centers and Clinics
5.3.1. Market size and forecast, by region
5.3.2. Market analysis, by country
5.4. Others
5.4.1. Market size and forecast, by region
5.4.2. Market analysis, by country
CHAPTER 6: DRUG DELIVERY DEVICES CAMERA MARKET, BY REGION
6.1. OVERVIEW
6.1.1. Market size and forecast
6.2. North America
6.2.1. Key market trends and opportunities
6.2.2. North America Drug delivery devices market, by country
6.2.2.1. U.S.
6.2.2.1.1. U.S. Drug delivery devices market, by device type
6.2.2.1.2. U.S. Drug delivery devices market, by end user
6.2.2.2. Canada
6.2.2.2.1. Canada Drug delivery devices market, by device type
6.2.2.2.2. Canada Drug delivery devices market, by end user
6.2.2.3. Mexico
6.2.2.3.1. Mexico Drug delivery devices market, by device type
6.2.2.3.2. Mexico Drug delivery devices market, by end user
6.2.3. North America Drug delivery devices market, by device type
6.2.4. North America Drug delivery devices market, by end user
6.3. Europe
6.3.1. Key market trends and opportunities
6.3.2. Europe Drug delivery devices market, by country
6.3.2.1. Germany
6.3.2.1.1. Germany Drug delivery devices market, by device type
6.3.2.1.2. Germany Drug delivery devices market, by end user
6.3.2.2. France
6.3.2.2.1. France Drug delivery devices market, by device type
6.3.2.2.2. France Drug delivery devices market, by end user
6.3.2.3. UK
6.3.2.3.1. UK Drug delivery devices market, by device type
6.3.2.3.2. UK Drug delivery devices market, by end user
6.3.2.4. Italy
6.3.2.4.1. Italy Drug delivery devices market, by device type
6.3.2.4.2. Italy Drug delivery devices market, by end user
6.3.2.5. Spain
6.3.2.5.1. Spain Drug delivery devices market, by device type
6.3.2.5.2. Spain Drug delivery devices market, by end user
6.3.2.6. Rest of Europe
6.3.2.6.1. Rest of Europe Drug delivery devices market, by device type
6.3.2.6.2. Rest of Europe Drug delivery devices market, by end user
6.3.3. Europe Drug delivery devices market, by device type
6.3.4. Europe Drug delivery devices market, by end user
6.4. Asia-Pacific
6.4.1. Key market trends and opportunities
6.4.2. Asia-Pacific Drug delivery devices market, by country
6.4.2.1. Japan
6.4.2.1.1. Japan Drug delivery devices market, by device type
6.4.2.1.2. Japan Drug delivery devices market, by end user
6.4.2.2. China
6.4.2.2.1. China Drug delivery devices market, by device type
6.4.2.2.2. China Drug delivery devices market, by end user
6.4.2.3. Australia
6.4.2.3.1. Australia Drug delivery devices market, by device type
6.4.2.3.2. Australia Drug delivery devices market, by end user
6.4.2.4. South Korea
6.4.2.4.1. South Korea Drug delivery devices market, by device type
6.4.2.4.2. South Korea Drug delivery devices market, by end user
6.4.2.5. India
6.4.2.5.1. India Drug delivery devices market, by device type
6.4.2.5.2. India Drug delivery devices market, by end user
6.4.2.6. Rest of Asia-Pacific
6.4.2.6.1. Rest of Asia-Pacific Drug delivery devices market, by device type
6.4.2.6.2. Rest of Asia-Pacific Drug delivery devices market, by end user
6.4.3. Asia-Pacific Drug delivery devices market, by device type
6.4.4. Asia-Pacific Drug delivery devices market, by end user
6.5. LAMEA
6.5.1. Key market trends and opportunities
6.5.2. LAMEA Drug delivery devices market, by country
6.5.2.1. Brazil
6.5.2.1.1. Brazil Drug delivery devices market, by device type
6.5.2.1.2. Brazil Drug delivery devices market, by end user
6.5.2.2. South Africa
6.5.2.2.1. South Africa Drug delivery devices market, by device type
6.5.2.2.2. South Africa Drug delivery devices market, by end user
6.5.2.3. Saudi Arabia
6.5.2.3.1. Saudi Arabia Drug delivery devices market, by device type
6.5.2.3.2. Saudi Arabia Drug delivery devices market, by end user
6.5.2.4. Rest of LAMEA
6.5.2.4.1. Rest of LAMEA Drug delivery devices market, by device type
6.5.2.4.2. Rest of LAMEA Drug delivery devices market, by end user
6.5.3. LAMEA Drug delivery devices market, by device type
6.5.4. LAMEA Drug delivery devices market, by end user
CHAPTER 7: COMPANY PROFILES:
7.1. 3M Company
7.1.1. Company overview
7.1.2. Company snapshot
7.1.3. Operating business segments
7.1.4. Product portfolio
7.1.5. Business performance
7.2. AstraZeneca PLC
7.2.1. Company overview
7.2.2. Company snapshot
7.2.3. Operating business segments
7.2.4. Product portfolio
7.2.5. Business performance
7.2.6. Key strategic moves and developments
7.3. BECTON, DICKINSON AND COMPANY
7.3.1. Company overview
7.3.2. Company snapshot
7.3.3. Operating business segments
7.3.4. Product portfolio
7.3.5. Business performance
7.4. Boehringer Ingelheim group
7.4.1. Company overview
7.4.2. Company snapshot
7.4.3. Operating business segments
7.4.4. Product portfolio
7.4.5. Business performance
7.4.6. Key strategic moves and developments
7.5. Consort Medical plc
7.5.1. Company overview
7.5.2. Company snapshot
7.5.3. Operating business segments
7.5.4. Product Portfolio
7.5.5. Business performance
7.5.6. Key strategic moves and developments
7.6. GlaxoSmithKline plc
7.6.1. Company overview
7.6.2. Company snapshot
7.6.3. Operating business segments
7.6.4. Product portfolio
7.6.5. Business performance
7.6.6. Key strategic moves and developments
7.7. Insulet Corporation
7.7.1. Company overview
7.7.2. Company snapshot
7.7.3. Operating business segments
7.7.4. Product portfolio
7.7.5. Business performance
7.8. Medtronic Plc.
7.8.1. Company overview
7.8.2. Company snapshot
7.8.3. Operating business segments
7.8.4. Product portfolio
7.8.5. Business performance
7.9. Sulzer Ltd. (Medmix Systems AG)
7.9.1. Company overview
7.9.2. Company snapshot
7.9.3. Operating business segments
7.9.4. Product portfolio
7.9.5. Business performance
7.9.6. Key strategic moves and developments
7.10. West Pharmaceuticals Services, Inc.
7.10.1. Company overview
7.10.2. Company snapshot
7.10.3. Operating business segments
7.10.4. Product portfolio
7.10.5. Business performance
7.10.6. Key strategic moves and developments

LIST OF TABLES
TABLE 01. DRUG DELIVERY DEVICES MARKET, BY DEVICE TYPE, 2018–2026 ($MILLION)
TABLE 02. SMART CAPSULE FOR DRUG DELIVERY AVAILABLE IN THE MARKET
TABLE 03. DRUG DELIVERY DEVICES MARKET FOR SMART PILLS, BY REGION 2018–2026 ($MILLION)
TABLE 04. DRUG DELIVERY DEVICES MARKET FOR DRUG ELUTING STENTS , BY REGION 2018–2026 ($MILLION)
TABLE 05. DRUG DELIVERY DEVICES MARKET FOR DRUG ELUTING STENTS, BY REGION 2018–2026 ($MILLION)
TABLE 06. DRUG DELIVERY DEVICES MARKET FOR SAFETY SYRINGES, BY REGION 2018–2026 ($MILLION)
TABLE 07. DRUG DELIVERY DEVICES MARKET FOR TRANSDERMAL PATCHES, BY REGION 2018–2026 ($MILLION)
TABLE 08. DRUG DELIVERY DEVICES MARKET FOR OTHERS DRUG DELIVERY, BY REGION 2018–2026 ($MILLION)
TABLE 09. DRUG DELIVERY DEVICES MARKET, BY END USER, 2018–2026 ($MILLION)
TABLE 10. DRUG DELIVERY DEVICES MARKET FOR HOSPITALS AND DIAGNOSTIC CENTERS, BY REGION 2018–2026 ($MILLION)
TABLE 11. DRUG DELIVERY DEVICES MARKET FOR AMBULATORY SURGERY CENTERS AND CLINICS, BY REGION 2018–2026 ($MILLION)
TABLE 12. DRUG DELIVERY DEVICES MARKET FOR OTHER END USER, BY REGION 2018–2026 ($MILLION)
TABLE 13. DRUG DELIVERY DEVICES MARKET REVENUE, BY REGION, 2018–2026 ($MILLION)
TABLE 14. NORTH AMERICA DRUG DELIVERY DEVICES MARKET, BY COUNTRY, 2018–2026 ($MILLION)
TABLE 15. U.S. DRUG DELIVERY DEVICES MARKET, BY DEVICE TYPE, 2018–2026 ($MILLION)
TABLE 16. U.S. DRUG DELIVERY DEVICES MARKET, BY END USER, 2018–2026 ($MILLION)
TABLE 17. CANADA DRUG DELIVERY DEVICES MARKET, BY DEVICE TYPE, 2018–2026 ($MILLION)
TABLE 18. CANADA DRUG DELIVERY DEVICES MARKET, BY END USER, 2018–2026 ($MILLION)
TABLE 19. MEXICO DRUG DELIVERY DEVICES MARKET, BY DEVICE TYPE, 2018–2026 ($MILLION)
TABLE 20. MEXICO DRUG DELIVERY DEVICES MARKET, BY END USER, 2018–2026 ($MILLION)
TABLE 21. NORTH AMERICA DRUG DELIVERY DEVICES MARKET, BY DEVICE TYPE, 2018–2026 ($MILLION)
TABLE 22. NORTH AMERICA DRUG DELIVERY DEVICES MARKET, BY END USER, 2018–2026 ($MILLION)
TABLE 23. EUROPE DRUG DELIVERY DEVICES MARKET, BY COUNTRY, 2018–2026 ($MILLION)
TABLE 24. GERMANY DRUG DELIVERY DEVICES MARKET, BY DEVICE TYPE, 2018–2026 ($MILLION)
TABLE 25. GERMANY DRUG DELIVERY DEVICES MARKET, BY END USER, 2018–2026 ($MILLION)
TABLE 26. FRANCE DRUG DELIVERY DEVICES MARKET, BY DEVICE TYPE, 2018–2026 ($MILLION)
TABLE 27. FRANCE DRUG DELIVERY DEVICES MARKET, BY END USER, 2018–2026 ($MILLION)
TABLE 28. UK DRUG DELIVERY DEVICES MARKET, BY DEVICE TYPE, 2018–2026 ($MILLION)
TABLE 29. UK DRUG DELIVERY DEVICES MARKET, BY END USER, 2018–2026 ($MILLION)
TABLE 30. ITALY DRUG DELIVERY DEVICES MARKET, BY DEVICE TYPE, 2018–2026 ($MILLION)
TABLE 31. ITALY DRUG DELIVERY DEVICES MARKET, BY END USER, 2018–2026 ($MILLION)
TABLE 32. SPAIN DRUG DELIVERY DEVICES MARKET, BY DEVICE TYPE, 2018–2026 ($MILLION)
TABLE 33. SPAIN DRUG DELIVERY DEVICES MARKET, BY END USER, 2018–2026 ($MILLION)
TABLE 34. REST OF EUROPE DRUG DELIVERY DEVICES MARKET, BY DEVICE TYPE, 2018–2026 ($MILLION)
TABLE 35. REST OF EUROPE DRUG DELIVERY DEVICES MARKET, BY END USER, 2018–2026 ($MILLION)
TABLE 36. EUROPE DRUG DELIVERY DEVICES MARKET, BY DEVICE TYPE, 2018–2026 ($MILLION)
TABLE 37. EUROPE DRUG DELIVERY DEVICES MARKET, BY END USER, 2018–2026 ($MILLION)
TABLE 38. ASIA-PACIFIC DRUG DELIVERY DEVICES MARKET, BY COUNTRY, 2018–2026 ($MILLION)
TABLE 39. JAPAN DRUG DELIVERY DEVICES MARKET, BY DEVICE TYPE, 2018–2026 ($MILLION)
TABLE 40. JAPAN DRUG DELIVERY DEVICES MARKET, BY END USER, 2018–2026 ($MILLION)
TABLE 41. CHINA DRUG DELIVERY DEVICES MARKET, BY DEVICE TYPE, 2018–2026 ($MILLION)
TABLE 42. CHINA DRUG DELIVERY DEVICES MARKET, BY END USER, 2018–2026 ($MILLION)
TABLE 43. AUSTRALIA DRUG DELIVERY DEVICES MARKET, BY DEVICE TYPE, 2018–2026 ($MILLION)
TABLE 44. AUSTRALIA DRUG DELIVERY DEVICES MARKET, BY END USER, 2018–2026 ($MILLION)
TABLE 45. SOUTH KOREA DRUG DELIVERY DEVICES MARKET, BY DEVICE TYPE, 2018–2026 ($MILLION)
TABLE 46. SOUTH KOREA DRUG DELIVERY DEVICES MARKET, BY END USER, 2018–2026 ($MILLION)
TABLE 47. INDIA DRUG DELIVERY DEVICES MARKET, BY DEVICE TYPE, 2018–2026 ($MILLION)
TABLE 48. INDIA DRUG DELIVERY DEVICES MARKET, BY END USER, 2018–2026 ($MILLION)
TABLE 49. REST OF ASIA-PACIFIC DRUG DELIVERY DEVICES MARKET, BY DEVICE TYPE, 2018–2026 ($MILLION)
TABLE 50. REST OF ASIA-PACIFIC DRUG DELIVERY DEVICES MARKET, BY END USER, 2018–2026 ($MILLION)
TABLE 51. ASIA-PACIFIC DRUG DELIVERY DEVICES MARKET, BY DEVICE TYPE, 2018–2026 ($MILLION)
TABLE 52. ASIA-PACIFIC DRUG DELIVERY DEVICES MARKET, BY END USER, 2018–2026 ($MILLION)
TABLE 53. LAMEA DRUG DELIVERY DEVICES MARKET, BY COUNTRY, 2018–2026 ($MILLION)
TABLE 54. BRAZIL DRUG DELIVERY DEVICES MARKET, BY DEVICE TYPE, 2018–2026 ($MILLION)
TABLE 55. BRAZIL DRUG DELIVERY DEVICES MARKET, BY END USER, 2018–2026 ($MILLION)
TABLE 56. SOUTH AFRICA DRUG DELIVERY DEVICES MARKET, BY DEVICE TYPE, 2018–2026 ($MILLION)
TABLE 57. SOUTH AFRICA DRUG DELIVERY DEVICES MARKET, BY END USER, 2018–2026 ($MILLION)
TABLE 58. SAUDI ARABIA DRUG DELIVERY DEVICES MARKET, BY DEVICE TYPE, 2018–2026 ($MILLION)
TABLE 59. SAUDI ARABIA DRUG DELIVERY DEVICES MARKET, BY END USER, 2018–2026 ($MILLION)
TABLE 60. REST OF LAMEA DRUG DELIVERY DEVICES MARKET, BY DEVICE TYPE, 2018–2026 ($MILLION)
TABLE 61. REST OF LAMEA DRUG DELIVERY DEVICES MARKET, BY END USER, 2018–2026 ($MILLION)
TABLE 62. LAMEA DRUG DELIVERY DEVICES MARKET, BY DEVICE TYPE, 2018–2026 ($MILLION)
TABLE 63. LAMEA DRUG DELIVERY DEVICES MARKET, BY END USER, 2018–2026 ($MILLION)
TABLE 64. 3M: COMPANY SNAPSHOT
TABLE 65. 3M: OPERATING SEGMENTS
TABLE 66. 3M: PRODUCT PORTFOLIO
TABLE 67. ASTRAZENECA: COMPANY SNAPSHOT
TABLE 68. ASTRAZENECA: OPERATING SEGMENTS
TABLE 69. ASTRAZENECA: PRODUCT PORTFOLIO
TABLE 70. BECTON, DICKINSON AND COMPANY: SNAPSHOT
TABLE 71. BECTON, DICKINSON AND COMPANY: OPERATING SEGMENTS
TABLE 72. BECTON, DICKINSON AND COMPANY: PRODUCT PORTFOLIO
TABLE 73. BOEHRINGER INGELHEIM: COMPANY SNAPSHOT
TABLE 74. BOEHRINGER INGELHEIM: OPERATING SEGMENTS
TABLE 75. BOEHRINGER INGELHEIM: PRODUCT PORTFOLIO
TABLE 76. CONSORT: COMPANY SNAPSHOT
TABLE 77. CONSORT: OPERATING SEGMENTS
TABLE 78. CONSORT: PRODUCT PORTFOLIO
TABLE 79. GSK: COMPANY SNAPSHOT
TABLE 80. GSK: OPERATING SEGMENTS
TABLE 81. GSK: OPERATING SEGMENTS
TABLE 82. INSULET: COMPANY SNAPSHOT
TABLE 83. INSULET: OPERATING SEGMENTS
TABLE 84. INSULET: PRODUCT PORTFOLIO
TABLE 85. MEDTRONIC: COMPANY SNAPSHOT
TABLE 86. MEDTRONIC: OPERATING SEGMENTS
TABLE 87. MEDTRONIC: PRODUCT PORTFOLIO
TABLE 88. SULZER: COMPANY SNAPSHOT
TABLE 89. SULZER: OPERATING SEGMENTS
TABLE 90. SULZER: PRODUCT PORTFOLIO
TABLE 91. WEST PHARMA: COMPANY SNAPSHOT
TABLE 92. WEST PHARMA: OPERATING SEGMENTS
TABLE 93. WEST PHARMA: PRODUCT PORTFOLIO




LIST OF FIGURES
FIGURE 01. DRUG DELIVERY DEVICES MARKET SEGMENTATION
FIGURE 02. TOP PLAYER POSITIONING, 2018
FIGURE 03. TOP INVESTMENT POCKETS
FIGURE 04. LOW-MODERATE BARGAINING POWER OF SUPPLIERS
FIGURE 05. HIGH BARGAINING POWER OF BUYERS
FIGURE 06. MODERATE THREAT OF NEW ENTRANTS
FIGURE 07. MODERATE THREAT OF SUBSTITUTION
FIGURE 08. HIGH INTENSITY OF COMPETITIVE RIVALRY
FIGURE 09. IMPACT ANALYSES, DRUG DELIVERY DEVICES MARKET
FIGURE 10. COMPARATIVE SHARE ANALYSIS OF DRUG DELIVERY DEVICES CAMERAS FOR SMART PILLS, BY COUNTRY, 2018 & 2026 (%)
FIGURE 11. COMPARATIVE SHARE ANALYSIS OF DRUG DELIVERY DEVICES MARKET FOR DRUG ELUTING STENTS, BY COUNTRY, 2018 & 2026 (%)
FIGURE 12. COMPARATIVE SHARE ANALYSIS OF DRUG DELIVERY DEVICES MARKET FOR DRUG ELUTING STENTS, BY COUNTRY, 2018 & 2026 (%)
FIGURE 13. COMPARATIVE SHARE ANALYSIS OF DRUG DELIVERY DEVICES MARKET FOR SAFETY SYRINGES, BY COUNTRY, 2018 & 2026 (%)
FIGURE 14. COMPARATIVE SHARE ANALYSIS OF DRUG DELIVERY DEVICES MARKET FOR TRANSDERMAL PATCHES, BY COUNTRY, 2018 & 2026 (%)
FIGURE 15. COMPARATIVE SHARE ANALYSIS OF DRUG DELIVERY DEVICES MARKET FOR OTHER DRUG DELIVERY, BY COUNTRY, 2018 & 2026 (%)
FIGURE 16. COMPARATIVE SHARE ANALYSIS OF DRUG DELIVERY DEVICES MARKET FOR HOSPITALS AND DIAGNOSTIC CENTRES, BY COUNTRY, 2018 & 2026 (%)
FIGURE 17. COMPARATIVE SHARE ANALYSIS OF DRUG DELIVERY DEVICES MARKET FOR AMBULATORY SURGERY CENTERS AND CLINICS, BY COUNTRY, 2018 & 2026 (%)
FIGURE 18. COMPARATIVE SHARE ANALYSIS OF DRUG DELIVERY DEVICES MARKET FOR OTHER END USER, BY COUNTRY, 2018 & 2026 (%)
FIGURE 19. 3M: NET SALES, 2016–2018 ($MILLION)
FIGURE 20. 3M: REVENUE SHARE BY SEGMENT, 2018 (%)
FIGURE 21. 3M: REVENUE SHARE BY REGION, 2018(%)
FIGURE 22. ASTRAZENECA: NET SALES, 2016–2018 ($MILLION)
FIGURE 23. ASTRAZENECA: REVENUE SHARE BY SEGMENT, 2018 (%)
FIGURE 24. ASTRAZENECA: REVENUE SHARE BY REGION, 2018 (%)
FIGURE 25. BD: NET SALES, 2016–2018 ($MILLION)
FIGURE 26. BECTON, DICKINSON AND COMPANY: REVENUE SHARE BY SEGMENT, 2018 (%)
FIGURE 27. BECTON, DICKINSON AND COMPANY REVENUE SHARE BY REGION, 2018 (%)
FIGURE 28. BOEHRINGER INGELHEIM: NET SALES, 2016–2018 ($MILLION)
FIGURE 29. BOEHRINGER INGELHEIM: REVENUE SHARE BY SEGMENT, 2018 (%)
FIGURE 30. BOEHRINGER INGELHEIM: REVENUE SHARE BY REGION, 2018 (%)
FIGURE 31. NET SALES, 2016–2018 ($MILLION)
FIGURE 32. CONSORT: NET SALES BY DIVISION, 2018 (%)
FIGURE 33. CONSORT: NET SALES BY REGION, 2018 (%)
FIGURE 34. GSK: NET SALES, 2016–2018 ($MILLION)
FIGURE 35. GSK: REVENUE SHARE BY SEGMENT, 2018 (%)
FIGURE 36. GSK: REVENUE SHARE BY REGION, 2018 (%)
FIGURE 37. INSULET: REVENUE, 2016–2018 ($MILLION)
FIGURE 38. INSULET: REVENUE SHARE BY SEGMENT, 2018 (%)
FIGURE 39. MEDTRONIC: NET SALES, 2016–2018 ($MILLION)
FIGURE 40. MEDTRONIC: REVENUE SHARE BY SEGMENT, 2018 (%)
FIGURE 41. MEDTRONIC: REVENUE SHARE BY REGION, 2018 (%)
FIGURE 42. SULZER: REVENUE, 2016–2018 ($MILLION)
FIGURE 43. SULZER: REVENUE SHARE BY SEGMENT, 2018 (%)
FIGURE 44. SULZER: REVENUE SHARE BY REGION, 2018 (%)
FIGURE 45. WEST PHARMA: REVENUE, 2016–2018 ($MILLION)
FIGURE 46. WEST PHARMA: REVENUE SHARE BY SEGMENT, 2018 (%)
FIGURE 47. WEST PHARMA: REVENUE SHARE BY REGION, 2018 (%)



【免責事項】
https://www.marketreport.jp/reports-disclaimer

★医療情報レポート[ドラッグデリバリーデバイスの世界市場:装置タイプ別(スマートピル、吸入器・ネブライザー、薬物溶出ステント、安全シリンジ、埋め込み型薬物送達デバイス、経皮パッチ、その他)、エンドユーザー別]についてメールでお問い合わせはこちら



◆H&Iグローバルリサーチ株式会社のお客様(例)◆